Jim Simons Exelixis, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXEL
# of Institutions
459Shares Held
246MCall Options Held
1.7MPut Options Held
1.02M-
Black Rock Inc. New York, NY34.9MShares$757 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$668 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA26.7MShares$579 Million2.95% of portfolio
-
State Street Corp Boston, MA13.1MShares$284 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.32MShares$115 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $6.98B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...